Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol Medical Dialogues Bureau10 April 2020 4:30 AM GMTMumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalatio...
Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus Medical Dialogues Bureau5 April 2020 9:11 AM GMTMumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalat...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 7:49 AM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Cipla gets USFDA final nod for Esomeprazole ANDA for Oral Suspension Medical Dialogues Bureau27 March 2020 7:21 AM GMTCipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is an AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's ...
Cipla joins hands with CSIR-IICT to develop coronavirus drug Medical Dialogues Bureau19 March 2020 6:40 AM GMTHyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the develop...
Dr VG Somani DCGI releases IPA guidelines on Market Complaints. Medical Dialogues Bureau2 March 2020 5:00 AM GMTThe guidelines were released at the recently concluded India Pharmaceutical Forum
USFDA inspection at Cipla manufacturing facility in Goa, warning letter issued Medical Dialogues Bureau27 Feb 2020 8:26 AM GMTNew Delhi: Drug firm Cipla recently announced that it has received a warning letter from USFDA for its goa Manufacturing Facility.Pursuant to...
Cipla arm inks pact for anti-psychotic drug Quetiapine Farhat Nasim11 Feb 2020 6:45 AM GMTNew Delhi: Cipla Medpro South Africa (Pty) Ltd, a wholly-owned subsidiary of Cipla Ltd, India, has recently concluded an exclusive agreement securing o...
Cipla acquires 4 key brands from Wanbury for up to Rs 89 crore Medical Dialogues Bureau10 Feb 2020 2:30 PM GMTNew Delhi: Drug firm Cipla on Saturday said it has acquiredfourbrandsfrom Wanbury Ltdto strengthen its presence in the women's health segment. ...
Cipla acquires 4 nutrition products from Wanbury for Rs 89 crore Farhat Nasim10 Feb 2020 6:28 AM GMTNew Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has acquired...
Cipla Q3 revenue up by 13pc at Rs 4371 crore Medical Dialogues Bureau6 Feb 2020 7:00 AM GMT 'We have had yet another good quarter: India business continued its momentum with strong double-digit growth in the prescription business; growth com...
Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 8:11 AM GMTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to dir...
